IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses
US7807471B2 · kind B2 · utility
3Cited by
8References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2007 |
| Grant date | Oct 5, 2010 |
| Priority date | — |
| Expiry date | Feb 1, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/34
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
An anti-IL-23 specific human Ig derived protein, isolated nucleic acids that encode at least one anti-IL-23 Ig derived protein, vectors, host cells, transgenic animals or plants, and methods of making and using thereof are useful as therapeutic and diagnostic compositions, methods and devices. The anti-IL-23 Ig derived protein preferably binds to one or more of the Seg 1, Seg 2, and Seg 3 epitopes of the p40 subunit of IL-23.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.